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A New Light for
Cancer Patients
PHOTODYNAMIC THERAPY EXTENDS LIVES

Contents

Message
from the
President

Robert L. Barchi, MD, PhD

As the financial drivers in U.S. health care
shift from volume-linked reimbursement
toward payment based on episodes of care,
medical outcomes and quality, Jefferson
graduates have a distinct advantage.
Medicine is indeed both an art and a
science. On the science side of the ledger,
our knowledge of disease pathophysiology,
our diagnostic arsenal and our therapeutic
options have all increased dramatically
over the past 50 years. Yet there remains
a critical component of medicine that is
still an art, one that forms in many ways
the basis for the intangible doctor-patient
relationship at the very core of the medical
profession. Certainly, a clinical history can
be obtained using a computer to interrogate a patient before the physician arrives.
This method is more efficient, perhaps, but
lacks the personal contact of a concerned
physician speaking directly to an anxious
patient. Likewise, a battery of initial laboratory tests might provide quantifiable clues
about that patient’s illness, but the laying
on of the physician’s hands in a skillful
physical examination will often yield those
insights more quickly, while at the same
time strengthening the supportive and therapeutic bond that must develop between
patient and physician. It would indeed be

a tragedy if modern medicine lost the value
of the “art” because of the overwhelming
pursuit of the “science.”
As a generation of senior faculty begins
to retire, instruction in these clinical diagnostic skills is becoming a lost art at many
other medical schools. Physicians trained at
Jefferson have the best of both worlds. They
are fully versed in the science of medicine
and skillfully deploy the latest medical technologies, techniques and diagnostic studies.
But they’re also equipped with a deep appreciation for the art of medicine, including the
elucidation of the medical history and the
physical exam that still form a critical basis
of our profession.
In my own specialty of neurology, the art
of clinical observation was a highly refined
skill in the generation of clinicians who were
my mentors and role models. Even now, I
learn more about a new patient’s problems
merely by observing him walking into my
office than I do from all the forms he filled
out prior to being called into consultation.
Before my patient even says hello, I know a
tremendous amount: how he gets up from a
chair, what his gait looks like, how he carries
his arms or how his eyes move. This focuses
the history I take and helps me identify
whether the primary complaint is the core
problem or a symptom of a condition the
patient doesn’t know about yet. While a full
neurological exam could take hours, like
other neurologists with my training, I have
already picked through the tree of physical
diagnoses as applied to what I have seen
and heard and can efficiently streamline
my interactions without sacrificing clinical accuracy. Physicians with such skills
can develop a differential diagnosis in their
minds that others might only obtain by
ordering layers of tests.
Jefferson has imbued its graduates with
expertise in physical diagnosis for nearly 200
years. Today, our curriculum explicitly reinforces these skills. We provide structured
practice with standardized and simulated
patients at Jefferson’s Clinical Skills and
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Simulation Center. Our faculty teach new
ways to use old-fashioned tools, such as
a stethoscope, to assess the heart, liver,
lungs and even bowels. They demonstrate
and validate students’ auditory detection
skills, for instance, by using a stethoscope
connected to infrared headphones that allow
students and faculty to listen to the same
sounds simultaneously.
As a result, our graduates know how to
take a clear and accurate patient history, how
to use their senses and intuition in a physical
exam to accelerate the path toward diagnosis
and, not least, how to express concern and
caring. They have a more balanced view of
the patient and his or her disease rather than
treating a patient as a set of symptoms and
laboratory studies.
Physical diagnosis skills are part of what
elevate a technically skilled physician to a
truly great clinician who doesn’t waste time
or money getting to a correct diagnosis.
Technology and testing are essential tools
to confirm or narrow down a differential
diagnosis and identify an effective course
of treatment. But they should never be a
crutch. Physicians who lack physical diagnosis skills tend to order significantly more
studies and scans.
As the economics of health care continue to
evolve, Jefferson-trained physicians possess a
competitive advantage that will serve them
well. We pass along this legacy of physical
diagnosis skills, derived from the collective
wisdom of earlier generations of physicians,
not as a romantic notion or historical artifact
but as a necessity for accurate and efficient
diagnosis and treatment.
At Jefferson, we teach physical diagnosis
skills because it’s good medicine.
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The Dean’s Column
In our metric-centric administrative culture,
medical schools are too commonly compared
on the basis of that which is most readily
quantifiable – college grade point averages
and MCAT scores of incoming students loom
large. Simplistic metrics such as these, reinforced by magazines catering to the allure of
“the best of this” and “the best of that” rankings, do a disservice to our training programs,
along with our profession at large. Through
their distorting lens, these evaluation schema
fail to register the most meaningful personal
attributes, the most impressive life accomplishments and the real potential of our
students. No one has designed a compelling
metric that fully captures the deeper human
qualities that truly distinguish one’s students
– the characteristics that drive a medical
school’s vibrancy and culture, and those
that predict how trainees will instantiate the
highest aspirations of their medical training
within society.
The heart and soul of Jefferson are so
much more than the grades and scores of
its students – they are reflected in their life
experiences. We recruit students who have
the broad range of intellectual and personal
skills needed for successful and varied careers
in medicine. Yes, these are students who
routinely emerge from their training as expert
diagnosticians and empathic caregivers. But
more than this, we are looking to them to
become leaders – in dimensions ranging from
discovery science to medical education to
healthcare reform. Our goal is to generate a
cadre of physicians who can function well in
diverse healthcare and societal settings. This
starts with the admission process. Diversity of
input allows for diversity of output.
This issue contains a fascinating profile of
Kanani Titchen, a former professional actor
who today is a fourth-year student (see page
18). As an aspiring pediatrician, Kanani’s capabilities were enriched by her years acting with a
theatrical repertory company, which strengthened her communication skills and deepened
her understanding of the human spirit.
As we celebrated the 50th anniversary of
women at JMC this past year, we were treated
to many vivid examples of the nontraditional
paths JMC women have taken to medicine,

past and present. I’d like to share just a few
from our current crew. Of course, the men of
our student body have similarly fascinating
backgrounds, but I’ll save their stories for
some other time.
As one of the founders of Philadelphia’s allwomen roller derby league, Kristi Dellabadia
traveled a circuitous route to medicine that
in retrospect makes perfect sense. After
high school, she obtained a two-year certificate as a veterinary technician. Kristi then
spent a decade working in critical care at
the University of Pennsylvania’s Matthew J.
Ryan Veterinary Hospital. A benefit of that
daytime job, free tuition, allowed her to earn
a bachelor degree in biology at night.
During those busy years, Kristi helped
launch Philly Roller Girls, which promotes
itself as a “league of athletic, ferocious, kickass chicks on wheels,” and competed with
the Liberty Belles travel team. Initially, she
considered becoming a veterinarian, but soon
realized that she felt more fulfilled meeting
the medical needs of people. As a 33-year-old
second-year medical student, she feels that all
those experiences help her listen to patients
more effectively and ask the right questions.
Joanelle Bailey discovered an interest in
medicine when she explored alternatives to
her first job out of college as a civil engineer.
During her two years at that job, Bailey
became a volunteer fire fighter. Training
included an EMT class with a mandatory
ambulance ride-along. Bailey soon realized
she just didn’t want to get off that ambulance. For the next four years, Bailey worked
as a paramedic. Her eagerness to know more
about her patients led her to Jefferson, where
she is now a third-year student.
Bailey, 30, says these experiences help her
maintain perspective on the stresses and
challenges of medical school. She also draws
on insights from her years as a high school
and collegiate pole-vaulter. One might
assume this sport cultivates courage. But
Bailey, who routinely launched herself higher
than 12 feet up and over a bar, is convinced
that the sport also reinforces traits such
as persistence, ambition and logic. Always
trying to anticipate the next step ahead, she
says, is a trait helpful in medicine.

Interesting people tend to attract others,
and at JMC, this has been snowballing. While
medical students with nontraditional educational and professional backgrounds are but a
minority on campus, they serve as a magnet
for other fascinating students. This was definitely the case for Bianca Grecu, a fourth-year
student and semi-professional bicycle racer
with Philadelphia’s Human Zoom women’s
cycling team. Her path to Jefferson, from
being an undergraduate public health major,
included a conventional year off as a clinical
researcher in anesthesia. Bianca spent much
of that year racing with her team in national
races and had the opportunity to guest ride
in the Nature Valley Grand Prix, a prestigious professional race on the USA Cycling
National Racing Calendar.
Bianca says she chose Jefferson because so
many students here have interesting backgrounds that motivate and inspire her. They’re
good company, she says, and open her eyes to
new ways of solving problems. Bianca enriches,
and is enriched by, those around her.
Medical education today is as much about
what students learn from one another as what
they learn from professors. When students
work together on small-group projects and in
community outreach settings such as studentrun JeffHOPE clinics, they draw upon one
another’s collective expertise, scholastic and
experiential. The unsolicited, uniformly positive feedback we get from residency program
directors about our trainees, assures us that
our emphasis on admitting “whole people” and
training “the whole physician” is indeed working.
When Jefferson admits students with
broad curricular backgrounds and experiential paths, we bring a more worldly and
informed view to the practice of medicine.
That’s an important element of our unwritten
curriculum, as we cultivate the talented
physicians-in-training who will lead health
care and public health in the years to come.

Mark L. Tykocinski, MD
Anthony F. and Gertrude M. DePalma Dean
Jefferson Medical College

The heart and soul of
Jefferson are so much
more than the grades and
scores of its students –
they are reflected in their
life experiences.
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Findings

Could a Tumor Suppressor Also Fight Obesity?

The hormone receptor guanylyl cyclase C
(GCC) is a known suppressor of colorectal
cancer tumors, but new evidence discovered by Jefferson faculty suggests it may
also help fight one of the country’s biggest
pandemics: obesity.
Reporting in the Aug. 25, 2011, online
issue of the Journal of Clinical Investigation,
Scott Waldman, MD, PhD, chair of
the Department of Pharmacology and
Experimental Therapeutics, and his
colleagues found that silencing GCC
affected appetite in mice – disrupting
satiation and causing obesity. Conversely,
mice who expressed the hormone receptor
knew when to call it quits at mealtime.
Revealing a never-before-shown endocrine
axis between the intestine and hypothalamus,
the research could provide novel therapeutic targets to control appetite, obesity and
metabolic syndrome – a combination of
medical disorders that, when occurring
together, increase the risk of developing cardiovascular disease and diabetes. This presents a
promising notion given that one-third of the
U.S. population is considered obese.
Until now, the role of GCC outside the
gut has remained elusive. Waldman and

A.

his team have previously shown its role
as a tumor suppressor and biomarker that
reveals occult metastases in lymph nodes,
but GCC’s role in appetite is new and
surprising territory.
“We were working with GCC-deficient
mice to look at its role in tumorigenesis in
the intestine,” Waldman said. “Then the
mice grew up, and we noticed something:
They got fatter. We couldn’t understand
why it was happening, because GCC is
expressed predominantly in the intestine.
There was no indication that it regulated
any function that had to do with metabolism and nutrient uptake.”
To investigate this, Waldman, who also
leads the Gastrointestinal Malignancies
Program at the Kimmel Cancer Center
at Jefferson, and his colleagues raised both
normal mice and GCC-deficient mice, tracking
their weight, satiation responses, hepatic and
serum triglyceride measurements, hormone
receptor expression and physical activity.
When the mice digested food, the
researchers found that the gut released
hormones into the bloodstream – not just
within the intestines – and up into the
brain, where the hormone receptors were

B.
Hypothalamus

triggered. Mice with GCC knew when to
stop, but hormone receptor-deficient mice
never got the message that their stomachs
were full. They simply kept eating and
became obese.
“They got to be diabetic and developed
metabolic syndrome, fatty livers and so on,”
Waldman said. “We ruled out the usual
suspects. Gastroenterology function was
normal. They weren’t more sedentary than
wild type mice; and they did not have
abnormal metabolism. We realized they just
had a different appetite.”
The research offers up a new neural-gut
axis that explains appetite more. But it still
raises some questions. Do obese people
possess little to no GCC? And if so, does that
mean obese people have a genetic disposition to gain weight? “It’s possible, but it’s
still unclear,” said Waldman. “There is the
possibility that obese people do not have
the receptor or they do not release enough
hormones to trigger the receptor. More
studies are needed to better explain this.”
“Obesity could be biological, and not
behavioral,” said Waldman. “There is no
evidence here that confirms that. However,
this new information opens that possibility.”

Neuron in brain
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nerve cell to signal
satiety to brain.
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GCC
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Prouroguanylin
is cleaved.

The brain signals a sense
of being “full” to the body,
which may affect appetite.
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cGMP, or cyclic GMP, is an intracellular
messenger molecule that translates extracellular
signals (here the uroguanylin) into intracellular
signals that direct the cell's behavior (here the
generation of a satiety or ‘fullness’ signal).
Stomach

Neuron in brain

GTP

Inactive
GCC Receptor

Hypothalamus

The receptor is
not activated and
guanylyl cyclase
enzyme is not
triggered.
Lumen
No cGMP is made, so there is no signal
telling the brain that the body is full.

Uroguanylin isn’t
cleaved and doesn’t
reach receptor.

GTP is a fundamental building block in the cell – it is a
"cousin" of ATP that is used to build DNA and RNA, as
well as other fundamental molecules, in the cell. One of
its functions is to serve as the precursor of the signaling
molecule cGMP.

Intestinal
villus

Blood circulates
from intestine.

Epithelial cells along the intestinal
villus send prouroguanylin into
the bloodstream.
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One month before her death,
Gladys Ariff danced until 2 a.m.
at her grandson’s wedding.

THE
OF

FOR PATIENTS WITH
ADVANCED BILE
DUCT CANCER

That was a high point, but only
one of many. Daily phone calls
from each of her six grandchildren punctuated the 14
months following her diagnosis
with advanced bile duct cancer.
Throughout that time, Ariff
also inspired a vibrant community of friends at her synagogue
with her zest for life and stylish
hats, which protected her
during a life-extending therapeutic regimen.
“We saw a woman living, not
dying,” recalls Ariff’s daughter,
Sharon Webb, who shared these
memories in the hope that
other patients might benefit
from the experimental photodynamic therapy that let her
mother experience these joyful
moments. Ariff passed away in
October 2010 at age 83, having
outlived the usual prognosis of
three to six months.

Ariff refused chemotherapy
and radiation; with so little
time left, she wasn’t willing
to endure their debilitating
side effects and limited
impact on life expectancy. Her
Wilmington, Del., physician
referred her to David Loren,
MD, associate director of
medical endoscopy at Jefferson,
who has treated nearly 30
bile duct cancer patients with
photodynamic therapy since
2009 – extending their lives
post-diagnosis typically by a
year or more.
While photodynamic therapy
has been the standard of care
in Europe for more than two
decades, it is not offered widely
for bile duct cancer in the United
States. The therapy has not
yet received FDA approval for
this use, though it is approved
for some esophageal and lung
cancers. Only four medical
centers in the United States treat
an estimated total of 100 patients
annually with photodynamic
therapy for bile duct cancer:
the Mayo Clinic, Weill Cornell
Medical College, Indiana
University and Jefferson.

Loren is currently recruiting
patients to participate in a multicenter clinical trial expected to
begin this year. Pinnacle Biologics,
which makes Photofrin®, the
photosynthesizing medication
used in the therapy, is funding
the trial.
By the time symptoms
appear, the timeline is virtually
the same for bile duct cancer
and the more common pancreatic cancer. In the United
States, 3,000 patients receive
the diagnosis of bile duct cancer
annually. Typically they have
experienced jaundice, weight
loss and itching as tumors
block the flow of bile from the

liver into the small intestine,
where bile plays a key role in
digestion. While the disease
may be considered curable
by surgery in its early stages,
most patients don’t find out
in time. When surgery is still
possible, the odds of extending
life expectancy through surgery
or photodynamic therapy are
often evenly matched.
Currently, more than 70
percent of bile duct cancer
patients hear the grim news
that their cancer cannot be
surgically removed. Their
limited treatment options
include radiation and chemotherapy that degrade quality
of life during a patient’s final
months, and stents to keep the
bile duct open. Unfortunately,
says Loren, these stents typically become useless after
tumor regrowth clogs the ends.
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“If doctors would refer patients
for an endoscopic evaluation to
identify whether their bile duct
is constricted, we would be
detecting way more bile duct
cancer nationally.”

“We saw a woman living, not dying.” — Sharon Webb, Ariff’s daughter

— Michel Kahaleh, MD, chief of advanced endoscopy,
Weill Cornell Physicians

L to R: Jason Giordano, CRNA;
Jason Lewis, MD; Ayana WilliamsSmith, ORT, ATS; and David Loren, MD,
in one of Jefferson’s endoscopy suites.

Photodynamic therapy
offers the prospect of an extra
year of life to patients who
must suddenly confront their
mortality. “What people are
looking for is to have extra
time with the people they love
and to not be burdened by the
side effects of chemotherapy
and radiation,” says Loren.
Photodynamic therapy keeps
bile duct tubes open by coring
them like an apple. Patients are
injected with photosensitizing
medication two days prior to the
two-hour endoscopic procedure,
which delivers tumor-killing
light via a 4-millimeter laser
fiber threaded carefully down
through the intestines and into
the bile ducts. The bile ducts
are reopened via bursts of laser
light focused on tumors, and
then stents are placed to keep
bile flowing. After treatment,
patients typically experience a
pain-free three months with no
need to visit a doctor, and then
return for another round.
For up to six weeks after the
therapy, patients must wear
hats and protective clothing to
block exposure to sunlight and

artificial light. These prevent
sunburn triggered by the photoactive medication. While the
treatment can be combined
with chemo and radiation, most
patients don’t choose this option.
In keeping with her upbeat
personality, Ariff embraced the
restrictions on light exposure
with gusto, triggering a fashion
phenomenon. Rejecting the hat
supplied by the hospital, she
asked her milliner to expand her
wardrobe of stylish hats. In solidarity, her friends likewise wore
their silliest and most colorful
hats in her presence. They were
a vivid sight at her Wilmington
synagogue, where Ariff also
inspired a community of volunteers to cater life-cycle events.
Her daughter recalls how every
woman among the 300 people at

Ariff’s funeral wore a hat: “Her
style became everyone’s style,
which added a touch of fun to
that time of sorrow.”
Restrictions on light exposure
in the aftermath of this therapy
are a deterrent for a significant
subset of patients. “For patients
who want to be outside, on the
beach or gardening, photodynamic therapy would not
improve their quality of life,”
Loren says. His long-term goal is
to develop a multifaceted treatment center for bile duct cancer
at Jefferson to treat more bile
duct cancer patients with photodynamic therapy and other
innovative therapeutics. “We
have other novel options available for patients. But they are as
yet unproven while we collect
data,” he says. Jefferson has one
of the nation’s highest-volume
interventional endoscopy units,
providing 20,000 procedures
each year, and the expertise of

dedicated pancreaticobiliary
surgeons and gastrointestinal
oncologists.
Michel Kahaleh, MD, chief
of advanced endoscopy at Weill
Cornell Physicians and primary
investigator of the upcoming
clinical trial for photodynamic
therapy, says, “The good news
is that photodynamic therapy
can downstage cancer if you
detect it early enough so that
the lesion can become surgically resectable. Jefferson has
become a major partner in the
fight against bile duct cancer.”
Bile duct cancer has become
a death sentence unnecessarily, says Kahaleh. “Academic
medical centers must increase
public awareness and accelerate
the process to get FDA approval
for photodynamic therapy. We
are obligated to take a stand and
educate patients and doctors to

promote early detection, treatment and a potential cure.”
However, adds Kahaleh,
“The real challenge is that this
is a totally unrecognized and
under-diagnosed disease. A lot
of people walk around with
bile duct cancer unrecognized
and then die from obstructive jaundice and infection. If
doctors would refer them for
an endoscopic evaluation to
identify whether their bile duct
is constricted, we would be
detecting way more bile duct
cancer nationally. And if we
could search for it earlier and
more aggressively, the prognosis would be much better.”
The price of the photosensitizing medication, Photofrin®,
recently increased sixfold,
bringing the total price tag
to $20,000 for each treatment
provided at 90-day intervals.
Medicare typically covers the
therapy, but other insurers
sometimes balk. Loren has
worked tirelessly to reduce
approval times with other
insurers even though it sometimes takes him many hours to

fight on behalf of a patient. He
notes that the typical threeto five-week approval timeline
just doesn’t make sense for
someone who has only three
to six months to live. “I haven’t
lost yet,” says Loren. “The
strong clinical data for this
treatment ultimately persuaded
independent review boards to
cover photodynamic therapy
treatments.”
After Ariff’s death, Loren’s
clinic planted trees in her
memory and mailed a card
to her family recalling how
“She brought light and joy to
everyone.” Inspired by that
insight, her family inscribed
the phrase on Ariff’s tombstone – just below the outline
of a jaunty hat.
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Celiac Disease:

Overcoming a Stealth Public Health Menace

E

veryone knows that a peanut butter
and jelly sandwich can be a culinary
death sentence for someone with a
severe peanut allergy.
Yet few people understand the potentially serious health consequences of eating
foods with even small quantities of gluten, a
protein found in wheat, rye and barley, for
people with celiac disease.
For people who have celiac disease, a weekly
communion wafer can lead to life-threatening health problems. This autoimmune
response to foods with gluten attacks and
disrupts basic cellular repair mechanisms
throughout the body and blocks the absorption of nutrients from food.
“Celiac disease has a protean and insidious effect throughout the body,” says
Anthony DiMarino Jr., MD, the William
Rorer Professor of Medicine and chief
of the Division of Gastroenterology and
Hepatology at Jefferson and co-director of
the Jefferson Celiac Center, which opened
in early 2011. With 30 physicians, specially
trained pathologists and a dedicated nurse
practitioner, the center is one of the largest
and most integrated providers of care for
celiac disease patients in the Philadelphia
region. It’s also the only Center City clinic
with a full-time registered dietician who
specializes in helping patients adapt to the
strictly gluten-free diet required to restore
their health.

A Stealth Disease

strict. Daily limits on gluten consumption
are equal to 1/50th of a slice of bread and
are easily reached via trace contaminants.
“Basically, you can never cheat,” says Emily
Rubin, RD, LDN, the division’s dietician. “I
try to focus on what patients can eat, not on
what they can’t eat, so that it doesn’t seem
so overwhelming. Everyone who follows a
gluten-free diet should feel better within a
couple of weeks and see their numbers come
down within six months and normalize
within a year.”
The big problem lies with trace contaminants. A hamburger can’t just be plucked
off a bun. Eggs can’t be cooked on the same
grill as pancakes. Even a peanut butter jar
can’t be shared with someone who spreads
it on bread; it might contain crumbs. The
experience of dining at a restaurant, being
a guest at a party or eating a home-cooked
meal can be fraught. “This disease is socially
challenging,” says Rubin. “Because you feel
like it’s annoying to nitpick.”
Currently, celiac disease affects 1 percent
of Americans. A Mayo Clinic study found
a nearly fivefold increase in celiac disease
incidence in current blood samples compared
with peer samples collected at Warren Air
Force Base in Wyoming during the 1950s.
Because the data are grounded in actual blood
You Can Never Cheat
measurements, the study demonstrates that
Symptoms can be controlled with a strictly the increase in celiac disease is not just a reflecgluten-free diet – with the emphasis on tion of growing awareness and diagnosis. By
Unfortunately, celiac is a stealth disease.
Half of those with the disease are symptom
free while they accumulate cellular damage.
Those with symptoms typically seek relief
for one or more ailments but usually don’t
realize they need treatment for the root cause.
They may experience miscarriages, stomach
pain, weight loss, anemia, migraines, osteoporosis, changes in bowel habits, numbing
and tingling in hands and feet and tiny blisters on elbows, arms and knees.
“Anyone with these symptoms, an autoimmune condition or a family history should
have a simple diagnostic blood test for celiac,”
says David Kastenberg, MD, co-director of
the Celiac Center. “Our job is to educate
physicians so they know what to look for.”
The blood test measures anti-tissue transglutaminase or anti-endomysial antibodies,
indicators of celiac. Even when these antibodies aren’t present, a genetic test can
reveal the presence of the disease. A human
leukocyte antigen (HLA) serotype of DQ2
or DQ8 will show up among 98 percent of
patients with the disease as well as among 30
percent of patients without celiac. A biopsy
of the small intestine, obtained via upper
endoscopy, confirms the diagnosis.
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assessing mortality rates among servicemen
from the 1950s whose frozen blood samples
revealed they had undiagnosed celiac disease,
the same study revealed a fourfold increase in
premature death.
Possible factors in the rising incidence of
celiac disease include the increased gluten
content of grains due to hybridization and
comparable increases in food allergies that
some attribute to the hygiene hypothesis (a
theory that the modern environment is so
clean that the immune system turns on itself).
Patients with celiac disease who fail to
maintain a gluten-free diet have an elevated
risk of developing intestinal lymphoma or
bowel cancer. Other serious problems occur
when the immune system, responding to
proteins in gluten, permanently damages
the villi, the hair-like projections that line
the small intestine like a shag carpet and
help the body absorb nutrients. A condition
called refractory sprue affects fewer than 1
percent of celiac patients, who then cannot
respond to a gluten-free diet because the
interior of their intestines has been permanently damaged – rather than a shag carpet,
the intestines look more like a tile floor, with
no villi present. Poor absorption of nutrients typically leads to a need for long-term mune diseases out there. Please take it seriously.
steroid therapy and frequent hospitaliza- Only 200,000 people in the United States have
been properly diagnosed, and almost three
tions for these patients.
million actually have the disease.”
Disease du Jour?
Bast became a patient of DiMarino in 1998.
In some ways, celiac disease has become a Five years later, she founded a nonprofit, the
victim of greater visibility. It is sometimes National Foundation for Celiac Awareness
mistakenly associated with gluten sensitivity, (NCFA), and asked DiMarino to join her sciena far less serious condition akin to lactose tific and medical advisory board, a role he’s
intolerance. People with gluten sensitivity held ever since. NCFA offers free continuing
feel better when they eat less gluten – medical education courses to physicians
but eating wheat, rye or barley doesn’t affect online, facilitates research and initiatives to
their health.
improve the quality of life for individuals with
People with celiac disease also encounter the disease, and even trains restaurant chefs
skepticism because gluten-free eating has and food-service managers so that children
joined the ranks of trendy diets – along the can eat safely in school cafeterias.
lines of South Beach and Atkins. “I actually
All too often, Bast hears from people who
had a doctor [not from Jefferson] say to me, don’t have sufficient medical support for
‘Oh, you have the disease du jour. Aren’t you their disease. “It’s not like you get diagnosed
in high fashion?’” recalls Alice Bast, who with celiac disease and go on your merry
was diagnosed with celiac disease in 1994. way. There is so much follow-up to be done,”
By that time, Bast, at 5’9” tall, weighed just she says. “It needs to be carefully managed.”
over 100 pounds and had suffered a full-term
More than a decade ago, DiMarino
stillbirth, three miscarriages and virtually the counted himself among the skeptics about
full checklist of celiac symptoms. “I tell physi- celiac disease. Then, two of his fellows
cians that celiac disease is one of the most enlisted his help in a study in which they
common yet most under-diagnosed autoim- determined that fewer than 50 percent of
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New Celiac Medication
Could Improve Health – and Golf Swing
The extra 15 yards Norm added to his golf drive have attracted even more attention off
the links than on.
That’s because he was among six Jefferson patients to participate in a recent multicenter clinical trial for a promising new medication for celiac disease, larazotide acetate.
For the prior 15 years, Norm had been unable to get his antibody levels under control.
During the trial, he didn’t know whether he was receiving a placebo or the actual
medication, but Norm was thrilled with the results: he gained 30 pounds and improved
his drive. As soon as the trial ended, he had to stop his medication, which is not yet on
the market. Both benefits disappeared.
Six months after the study, Anthony DiMarino Jr., MD, co-director of the Jefferson Celiac
Center, was permitted to break the blind. He learned that four out of six of his patients
who had participated in the clinical trial had actually received the medication; their
antibody counts had improved to normal levels.
Emily Rubin, RD, LDN,
reviews dietary options.

obstetricians, gastroenterologists and
primary care physicians understood the
link between celiac disease and miscarriage. “One of the signs of celiac is a woman
who has lost multiple pregnancies,” says
DiMarino. “This research has sparked my
involvement ever since.”
He vividly recalls one patient, a woman
in her early 30s who looked like the picture
of good health. Yet she had lost two fullterm pregnancies and suffered a series of
miscarriages over five years. The woman
and her husband had spent tens of thousands of dollars trying to get pregnant.
“Someone finally noticed that she had a
slightly lowered hemoglobin count and
referred her to me,” says DiMarino. “She
was one of those folks who had no, or
minimal, gastrointestinal symptoms. I put
her on a gluten-free diet. She was pregnant
within six months and had another baby
two years later.” DiMarino keeps pictures
of the two children in his office today.

“We hope this will be the next big thing,” says DiMarino, who is currently enrolling
patients in another clinical trial for larazotide acetate. “What’s so attractive is its safety:
it doesn’t get into the bloodstream or alter the immune system, blood pressure or heart
rate. You may be able to take it 30 minutes before a meal, and it tightens up the cells in
the intestine to block the absorption of accidentally consumed gluten.”
DiMarino, who has no financial connection to the medication or the company that makes
it, says, “If you lived in a bubble and never ate gluten again, celiac disease would go
away. With this medication, you can stay healthy and live in the real world. It should
protect you from the harmful effects of gluten if you’re not sure how food was prepared.
The truth is that gluten is so ubiquitous that it’s incredibly difficult to remove from
your diet.”
While this medication has potential to become the first FDA-approved drug for celiac
disease, it’s not there yet. In the meantime, Jefferson is engaged in a full range of
proven diagnostic and therapeutic regimens while also advancing understanding of ways
to diagnose and care for patients with celiac disease.
To reach the Jefferson Celiac Center,
call 215-9-CELIAC (or 215-923-5422).
A symptom checklist for celiac disease
is available at www.celiaccentral.org.

Anthony DiMarino Jr., MD, and
David Kastenberg, MD, co-directors
of the Jefferson Celiac Center.
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LIGHT THERAPY

for a
BLUE PLANET AND BEYOND
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Few treatments have emerged in psychiatry
that have relatively few side effects, are of
minimal cost and alleviate symptoms in less
than a week. Fortunately for people who suffer
from clinical seasonal affective disorder, or
SAD, light therapy is one of those rare treatments. “It’s striking, in the world of psychiatry,
how quickly light works as a therapeutic stimulus compared to pharmacological treatments,
which may take several weeks to provide
relief,” says George Brainard, PhD, neurology
professor and director of Jefferson’s Light
Research Program.
During fall and winter, 14 percent of the
U.S. population experiences some sub-clinical symptoms of SAD, a type of depression;
these symptoms sometimes include mild
weight gain, modest increased need for sleep,
tendency to be less socially interactive and
generally feeling worse during the short days
of late fall and winter. But for an estimated
2 percent of the population, symptoms can
be severe and debilitating and may include
feelings of hopelessness and weakness or
thoughts of suicide.

Bear-like Behavior

As its name implies, SAD is different from
typical depression in that its symptoms recur
annually in the fall and winter. People with
SAD also tend to crave carbohydrates and
may gain 10 to 30 pounds during the darkest
months of the year, whereas typical depression
is sometimes associated with loss of appetite.
Another striking difference is that SAD is
associated with hypersomnia, while people
with more typical depression often suffer from
insomnia. People with SAD tend to sleep from
10 to 14 hours a day. “The weight gain and
sleep is similar to bears who store up food for
hibernation in the winter,” says Brainard.
Until recently, bright white fluorescent
light has been the gold standard for treating
SAD. A 1981 study showed that symptoms
significantly diminished in seven to 10 days
when patients sat by a 2-by-4-foot panel of
bright fluorescent light for up to four hours

each day. The current standard of treatment is bright white light therapy for 30
to 60 minutes first thing in the morning
upon awakening. In the last decade, however,
Brainard and colleagues have discovered that
specific wavelengths of light corresponding
to different colors appear to be more potent
than others at alleviating SAD symptoms.
The difference lies not in how we perceive
the colors, but on an unconscious level.
Light travels from the retina into the brain
through two pathways. The more commonly
known pathway leads to the occipital lobe,
affecting our vision. The other pathway stimulates biological and behavioral responses,
in part by triggering the pineal gland, which
secretes melatonin, the hormone that affects
sleep and has a role in controlling circadian rhythms. A study by Brainard and his
colleagues showed the wavelength that has
the greatest influence on the pineal gland
is 464 nanometers, which corresponds to
blue – not coincidentally the color of the sky.
Red, by contrast, is least effective.

On the Right Wavelength

In a Phase I clinical trial, just 45 minutes a
day in front of a blue light panel was shown
to significantly reduce symptoms of SAD,
compared with a placebo red light control.
Blue light also elicited a 50 to 60 percent
remission rate, similar to bright white fluorescent light, but at a much lower dosage in
terms of brightness and time. “By getting
the wavelength right, you can use a gentler
light, which is an important finding for SAD
treatment, since it doesn’t cause headaches
or eye strain like a stronger white light can,”
says Brainard.
Light therapy devices are commercially
available in several forms, including light
panels, workstations, dawn simulators and
head visors. Most light therapy products
use white light, but companies like Philips
are emerging as leaders in the light therapy
marketplace and now offer products with
blue light-emitting diodes (LEDs).

George Brainard, PhD
At Jefferson, light therapy research is moving
beyond SAD treatment. Brainard is working
with NASA to create a dynamic lighting
system for the International Space Station,
with the goal of reducing chronic sleep deprivation among astronauts.
“Astronauts are some of the healthiest people
in the world, but even the toughest person
can collapse from chronic sleep deprivation,” said Brainard. Back on Earth, such
research could have significant implications
for the 20 percent of the U.S. population
that works in jobs that require alertness
long after the sun goes down. What began
as a treatment for seasonal depression, light
therapy is helping even the healthiest among
us sleep (and wake) better.
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Jefferson Faculty
Kathleen Squires, MD:
Working to Make a World of Difference for Patients with HIV
A walk through a village in Indonesia when she was 6 years old set
the course of Kathleen Squires’ life. There, she and her father saw
a man with bulging legs suffering from a disease she now knows
as elephantiasis, a rare lymphatic disorder.
Her compassionate father, whose job with an oil company required
the family to move to locations around the world, commented how
unfortunate it was that people there didn’t have access to good
medical care. “The family legend is that I declared right then that
I would become a doctor to help people like that,” recalls Squires.
As director of Jefferson’s Division of Infectious Diseases since
2005, Squires is known for her expertise in HIV clinical care and
research, which aligns with her lifelong interest in helping disadvantaged people. “What’s clear is that this infection has settled into
a population with few economic resources,” she says.
Jefferson’s clinic treats more than 1,000 HIV patients annually, nearly one-third of whom are uninsured or underinsured
and receive care thanks to a grant from the City of Philadelphia.
Patients may select established treatment protocols or participate
in one of five clinical trials currently open to improve treatment
regimens and evaluate new treatment options.
“Many of our patients are among the working poor and can’t afford
HIV medications that typically cost $1,000 a month,” Squires
says. “This grant enables our clinic to help patients obtain needed
services and health insurance. It’s also critical to our research:
unless we provide treatment to people with HIV who are impoverished, we won’t be at the forefront of understanding this disease.”
Under Squires’ leadership, Jefferson’s Division of Infectious
Diseases provides expert consults to physicians who encounter
obscure diseases from the developing world as well as ailments
more typically found in the Philadelphia region. This list
ranges from pneumonia and Lyme disease to MRSA infections,
drug-resistant tuberculosis and endocarditis and osteomyelitis,
infections linked to artificial heart valves or bones, respectively.
Squires recently shared her thoughts on her field and career.
Q. What inspired your interest in HIV research and treatment?
A. 	My career began at the dawn of AIDS, which was first
reported in 1981, the year I graduated from medical school.
I worked at the epicenter of the epidemic during my fellowship at Weill Cornell Medical College in New York. It has
been an incredible journey for me since. AIDS has evolved
from a uniformly fatal infection that caused young, vibrant

people to wither away and die months after diagnosis into
a chronic condition managed with a one-pill-a-day regimen.
	I am especially interested in how men and women fare differently with antiretroviral therapy. For instance, I’m trying to
tease out whether higher discontinuation rates for antiretroviral therapy among women reflect problems with toxicity, or
the reality that most HIV-infected women are single parents
who can’t participate in clinical trial schedules.
Q.	How has your interest in international travel dovetailed
with your work?
A.	During my childhood, I lived in Indonesia, Nigeria, Brazil,
Puerto Rico and Australia. While I have lived in the United
States since high school, my career has enabled me to continue
my world travels. Most HIV conferences are held outside the
United States.
Q.	What do you hope will be the legacy of your contribution
to medicine?
A.	W hen I first saw HIV in New York, it primarily occurred
among gay men. In the medical and lay communities, there is
still pervasive under-recognition that this sexually transmitted
disease affects men and women equally. I frequently hear ‘this
woman has a false-positive HIV test. Can you help me sort
this out?’ In fact, she often does have HIV.
	My proudest achievement would be to further contribute to
public awareness that HIV affects both men and women;
to identify how this disease affects women, especially during
child-bearing years; and to define how treatment protocols
for men and women should differ.
Q. What advances do you hope to see in HIV treatment?
A. 	HIV is an absolutely preventable disease – yet its incidence rate
hasn’t changed over the last decade. Every year, 60,000 new
cases of HIV are diagnosed in the United States. Over the next
decade, I would like to see new infection rates drop and more
patients receive needed therapies, which would reduce forward
transmission.
	Most people with HIV live in resource-poor settings. In many
parts of the world outside the United States and Europe, this
diagnosis is still a death sentence. While global health initiatives are changing that picture, many people share my concern
that the economy will slow our progress.
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For Former Actor, Pediatrician
is the Role of a Lifetime
Until Kanani Titchen was in her 30s, she was more likely to portray
a physician than to consider becoming one herself. A former actor,
Titchen is now a fourth-year JMC student. While her path to Jefferson
may have been circuitous, her theatrical experience informs her work
with patients today, having taught her how to put herself in other
people’s shoes.
After graduating from Tufts University with a dual degree in music
and psychology accompanied by a fascination with biology, Titchen,
originally from Hawaii, moved to San Diego, where she half-heartedly
looked for science jobs. “Something was nagging at me,” she says. “I
was 21 years old. It was the only time I felt like I could pursue music
and theater without repercussions.”
After a few interviews for entry-level science jobs, she realized she
was not yet ready to pursue science. She needed to give acting a shot.
Titchen was accepted to the repertory company at the Lamb’s
Players Theater, with which she performed and toured for the next
four years. In the acting world, being in a repertory company is a
coveted gig because of the steady work it provides. Still, her salary was
not enough to live on – so, like many actors, she sought other work
and taught acting to students in kindergarten through 12th grade.
Despite her busy and unpredictable schedule, she also volunteered at
a nonprofit organization working with at-risk youth, teaching them to
write, produce and perform plays with positive messages.
After several other acting and teaching jobs in San Diego, Titchen
moved to New York City to be a sound technician for a short-run

production on Broadway. In New York, Titchen watched artists much
older than she still struggling to succeed. It was then that she realized
it was time for a change. “I needed to break the rhythm,” she says. “I
needed to be bold and start something new.”
Tapping into her love of science and her undergraduate experience
in behavioral research, Titchen got a job at an international nongovernmental organization doing research on sexually transmitted
diseases. The position gave her lab experience and came with an
education stipend that she used for a physiology course at Columbia
University. She fell in love with the subject matter.
Even though a medical degree was still a distant thought at the
time, she enrolled in Columbia’s post-baccalaureate program. “I
figured I’d get the basic credits out of the way and then decide what
to do,” she explains. A job at an emergency room clinched the idea of
medical school. “Finally, my skills working with people and science
were coming together,” she says.
Titchen, 36, is among a small subset of older students on campus.
As such, she appreciates Jefferson’s size and the vibrant connections
formed among peers and mentors who, like her, experienced other
careers prior to medicine. Titchen plans to become a pediatrician, a
specialty she hopes will allow her to incorporate advocacy and preventive medicine. “I just love pediatrics,” she says. “It’s the greatest feeling
to see a kid go from miserable to smiling.”
As a soon-to-be JMC graduate and pediatrician, the stage is set for
her career’s second act.
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Hajnoczky

Menko

Liu

Oshinsky

Rattan

People
Dean’s Pilot Programmatic Research
Grant Initiative Awards Announced

JMC Dean Mark L. Tykocinski, MD,
announced recipients of the Dean’s Pilot
Programmatic Research Grant Initiative for
2011 in October. These $50,000 awards are
used to provide seed money for the generation of data leading to the submission of
successful NIH programmatic grants. In the
latest funding cycle, the awardees were:

Most

Lisanti

Headlines
• Karen Knudsen, PhD, Department of
Cancer Biology
Prostate Cancer Working Group
• Gyorgy Hajnoczky, MD, PhD, Department
of Pathology, Anatomy & Cell Biology
Mitochondrial Pathogenesis Working Group
• Sue Menko, PhD, Department of Pathology,
Anatomy & Cell Biology
Vision Research Center

Liu Named Director of
Radiosurgery Physics at JHN

Haisong Liu, PhD, associate professor in
the Department of Radiation Oncology, has
been named director of radiosurgery physics
for the Division of Stereotactic Radiosurgery
at Jefferson Hospital for Neuroscience. For
the past three years, Liu has worked in the
Bodine Center for Radiation Therapy at the
Kimmel Cancer Center as a senior physicist.

Oshinsky Honored by Headache Society

Michael L. Oshinsky, PhD, assistant professor
of neurology and a member of the Jefferson
Headache Center team, received the 2011
Harold G. Wolff Lecture Award for creating a
new animal model of migraine headache. The
award is granted annually by the American
Headache Society for the best paper on headache, head or face pain and the nature of pain
itself. Oshinsky won for his research paper,
“Spontaneous Trigeminal Allodynia in Rats: A
Model of Primary Headache.”

Rattan Awarded $1 Million NIH Grant

Satish C. Rattan, DVM, professor of medicine in the Division of Gastroenterology
and Hepatology, was awarded a grant for
more than $1 million by the National
Institutes of Health to continue his research
on rectoanal motility disorders. Rattan’s
laboratory has been pursuing studies to
determine the factors that regulate basal
tone in the internal anal sphincter muscle.
This grant is one of the longest continuously funded grants by NIH.

Schlaff Named Chair of Ob-Gyn

Sergio Jimenez, MD,
Honored by Royal
College of Physicians

Schlaff

Sergio Jimenez, MD (seated, far right), professor in the Department of Dermatology
and Cutaneous Biology, co-director of the Jefferson Institute of Molecular Medicine and
director of the Division of Connective Tissue Diseases, was invested as an Honorary
Fellow of the Royal College of Physicians in recognition of his exceptional services to
the practice of medicine at a ceremony in London in July 2011. Royal College President
Sir Richard Thompson (seated, center) and past president Dame Carol Black (seated,
second from right) participated in the ceremony. Also pictured are other new fellowship
recipients and the Royal College Fellows who sponsored their nominations.

William Schlaff, MD, has been appointed
chair of the Department of Obstetrics
and Gynecology. Schlaff comes from the
University of Colorado School of Medicine,
where he was chief of reproductive endocrinology and infertility and where he founded
the division of reproductive endocrinology.
He has been continuously funded by the
National Institutes of Health for 15 years.

New Gene Therapy Ready
for Clinical Trials

Research found that tamoxifen combined
with dasatinib, a protein-tyrosine kinase
A promising gene therapy developed in inhibitor, reverses the chemo-resistance
part at Jefferson’s Center for Translational caused by cancer-associated fibroblasts
Medicine to prevent and reverse congestive in the surrounding tissue by normalizing
heart failure is on the verge of clinical trials. glucose intake and reducing mitochondrial
Reporting in the online July 20, 2011, oxidative stress, the process that fuels the
issue of Science Translational Medicine, cancer cells. This combination resulted in
cardiology researchers demonstrated the nearly 80 percent cancer-cell death, the
feasibility, long-term therapeutic effective- team reported – a two- to threefold increase
ness and safety of S100A1 gene therapy in compared with tamoxifen alone.
“The drugs have no effect when they are
a large-animal model of heart failure under
conditions approximating a clinical setting. used alone – it’s in unison that they effec“The reversal of cardiac dysfunction in tively kill the cancer cells in the presence of
this preclinical heart failure model in the fibroblasts,” said Lisanti. “This opens up the
pig – by restoring S100A1 levels in practi- door for possible new treatment strategies.
cally the same setting as in a patient – is This ‘synthetic lethality’ may help patients
remarkable and will pave the way for a clin- overcome resistance in the clinic.”
ical trial,” said Patrick Most, MD, adjunct
assistant professor of medicine at Jefferson Jefferson Ranks among Nation’s Best
Thomas Jefferson University Hospitals again
and lead author of the study.
achieved top rankings in U.S.News & World
Report’s 2011 Best Hospitals survey – with
Leukemia Drug Could Help
top marks in a record-setting 11 specialty
Breast Cancer Patients
A leukemia chemotherapy drug may help areas.
U.S.News & World Report ranked Jefferson
breast cancer patients who don’t respond
14th
nationally for orthopedics and 12th
to tamoxifen obtain therapeutic benefits,
according to a study led by Michael P. nationally for rehabilitation medicine.
Lisanti, MD, PhD, professor and chair of Jefferson was nationally ranked in nine addithe Department of Stem Cell Biology and tional specialties: cancer; gastroenterology;
Regenerative Medicine and a member of geriatrics; gynecology; pulmonology; urology;
the Kimmel Cancer Center. The findings diabetes and endocrinology; neurology and
were reported in the Aug. 1, 2011, issue of neurosurgery; and ear, nose and throat.
Jefferson also ranked in the top 25 percent of
Cell Cycle.
hospitals nationally for nephrology, rheumatology and cardiology/cardiac surgery.
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Professor Welcomes JMC
Students for Thanksgiving

Schnell

Headlines continued
Single Vaccines May Protect
Against Rabies, Ebola

Researchers from Jefferson and other institutions, including the National Institute of
Allergy and Infectious Diseases, have developed single vaccine candidates to protect
against both rabies and the Ebola virus.
Successfully tested in mice, the bivalent
vaccines have several advantages over other
Ebola vaccine candidates that could accelerate its development for use in humans
and primates. Built on the same platform as
the already approved and financially viable
rabies vaccine, the new vaccine protects
at-risk populations against two viruses,

Kastenberg

Weitz

This year marked the sixth Thanksgiving
dinner for JMC students hosted by
Joseph Majdan, MD, assistant professor
of medicine and director of professional
development at Jefferson, and his wife,
Anita. Twenty-seven students who
were unable to travel during the holiday
joined the Majdans at their home and
consumed an impressive 30 pounds
of turkey.

Medical Frontiers
not just one, making it an effective and
ideal public health tool. The findings were
published Aug. 17, 2011, online in the
Journal of Virology.
“Many Ebola vaccine candidates have
been proved effective, but none are close
to licensure,” said Matthias Schnell,
PhD, director of the Jefferson Vaccine
Center and professor in the Department
of Microbiology and Immunology. “One
of the challenges is the market. There’s
a rather limited incentive in creating
a vaccine for Ebola. But these vaccines
could change that.”

Jefferson Hosts Ninth
Annual Awards Gala
Jefferson hosted its Ninth Annual Jefferson
Awards Gala Nov. 1, 2011, at the
Philadelphia Marriott Downtown. Every
year, this event honors two members of
the Jefferson community whose leadership
profoundly affects the field of medicine.
Honorees for 2011 were Howard Weitz,
MD, the Bernard L. Segal Professor of
Clinical Cardiology, chief of the Division of
Cardiology and director of the Jefferson
Heart Institute; and Ira Lubert, a local
business leader and philanthropist who
named the Sidney and Ethal Lubert Plaza on
Jefferson’s campus in honor of his parents.
The gala raised more than $1 million for
advanced heart care programs at Jefferson.

Jefferson Offers New Colonoscopy
Prep Option

Jefferson gastroenterologists are offering a
new colonoscopy preparation option designed
to motivate more people to get colonoscopies
and to improve prevention of colon cancer.
David M. Kastenberg, MD, associate
professor of medicine in the Division
of Gastroenterology and Hepatology, and
his team found that colonoscopy preparation
medication taken in two doses separated by
three hours the same day as the procedure is
just as effective as typical preparations beginning with medications given the night before.
Benefits include less sleep loss, less workday
interference and fewer complaints of side
effects. Many people refrain from having
colonoscopies to avoid the time-consuming
overnight protocol.

Jefferson Launches Wholly Robotic
Cardiac Surgeries

In September 2011, cardiothoracic surgeons
at Jefferson began performing wholly robotic
cardiac surgeries, beginning with a mitral
valve repair. “This is the next step in the
advancement of our robotics program,” said
Howard Weitz, MD, director of the Jefferson
Heart Institute, the Bernard L. Segal Professor
of Clinical Cardiology and chief of the
Division of Cardiology. Jefferson is the first
hospital in Philadelphia to perform wholly
robotic mitral valve repair. The Division of
Cardiothoracic Surgery previously conducted
partial robotic surgeries using the robotic
arm for access and better visualization in and
around the heart.

Longtime Faculty Member Creates Alumni Giving Incentive Fund
Last spring, Robert L. Brent, MD, PhD, a
JMC faculty member since 1955 who has
established four endowed scholarships
at Jefferson, and his wife introduced the
Robert and Lillian Brent Alumni Giving
Incentive Fund, which they created
to increase alumni giving and inspire
generosity in future graduates. The Class of
2011 is the first to be part of this program.
The Brents have made a donation to
the annual fund in each graduating
student’s name for the first five years after
graduation. At the end of five years, the

class will have an enviable 100 percent
giving participation. After five years, it will
be up to the class to continue its 100
percent giving record.
Brent has emphasized the importance of
giving throughout his lengthy career. In
1974, JMC’s student newspaper published
an article, “Eight Degrees of Charity,” that
he submitted as a faculty member. He
recently revised the piece:
Maimonides, the twelfth century Hebrew
scholar, described eight degrees of

charity … The highest degree is to
provide a means whereby the recipient
will become self-sufficient and in turn
be able to contribute to society. In
all likelihood, Maimonides could not
have foreseen the plight of the private
university in the twenty-first century –
but there is no doubt that he would
have considered university support
the highest level of philanthropy.
Maimonides also said, ‘No one ever
becomes impoverished by giving charity.’
“I guarantee you that the gratification
and joy of sustaining an institution of
education will become a very rewarding
part of your life,” Brent has told
Jefferson scholars. “For the students
that have read the Hippocratic Oath,
you know that it states that physicians
are responsible for the education of
future physicians.”
Brent, a distinguished professor of
pediatric radiology and pathology at
Jefferson and at Nemours/A.I. duPont
Hospital for Children, has received several
honors recently, including being named
2011 Castle-Connolly National Physician
of the Year in recognition of excellence in
clinical care and receiving the William Liley
Medal, awarded to pioneers in the field of
perinatal medicine.
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ClassNotes
’49

Gerald Marks was recently
honored by the Pennsylvania
Society of Colon and Rectal
Surgeons, which has established an
annual lectureship in his name. He
is proud to have played tennis with
his son, Richard Marks, MD ’88,
in last year’s National Super Senior
Father and Son Championship,
in which they received national
ranking. He lives in Penn Valley, Pa.

for a lifetime of career activities
that have advanced psychiatry.
Field lives in Philadelphia.

’67

David H. Miller retired in July 2011
after 38 years of practicing ophthalmology. He was a founding member
of Tri-County Eye Physicians and
Surgeons in Bucks County, Pa.
Miller lives in Newtown, Pa.

L. Roy Newman is retired from
the solo practice of pediatrics and
adolescent medicine. He serves as
a volunteer teacher of first-year
Jefferson medical students. A resident of Rydal, Pa., he is a director of
the Elkins Park, Pa., volunteer fire
company and provides reading and
math mentoring to third-graders
who live in the Northern Liberties
neighborhood of Philadelphia.

’54

Howard L. Field has received a
Philadelphia Psychiatric Society
Lifetime Achievement Award,
which is given to a Society member

James A. Sumerson retired from the
practice of otolaryngology and head
and neck surgery in July. He reports
that he had a wonderful career, both
in private practice and in his association with Jefferson as a clinical
associate professor. He plans to stay
on as webmaster for Advanced ENT
in South Jersey; travel with his wife,
Helene; and spend more time with
his four grandchildren. He lives in
Cherry Hill, N.J.

’70

Harvey Lefton is president-elect of
the Philadelphia County Medical
Society and is hoping to keep in

the tradition of Dr. Samuel Gross
who was president in 1853. He lives
in Huntingdon Valley, Pa.

’72

Robert E. Rinaldi is working for
a weight-loss clinic in Naples, Fla.
He reports that he and his wife,
Cynthia, are enjoying both work
and play in paradise.

’74

Joseph R. Berger is entering his
17th year as chair of the neurology
department at the University of
Kentucky and says his research and
interest in progressive multifocal
leukoencephalopathy have kept him
very busy. His oldest son pursued a
career in medicine and is finishing a
plastic surgery residency at Stanford.
Berger lives in Lexington, Ky.

’96

Tiffany Hughes has started a
private practice in Philadelphia
in psychiatry and psychoanalytic
psychotherapy. She is enrolled as

M

y modification of Einstein’s Theory of Relativity holds that the older one gets, the faster time
moves – especially if you enjoy what you are doing. I’m coming to the end of my term as Alumni
Association president, and these two years have flown by because I have
thoroughly enjoyed representing the biggest and best medical school alumni
in the country.
I would like to thank the people who made this job so much fun, including
Phil Marone, MD ’57, MS ’07, and his right-hand staffer, Toni Agnes; the
members of the Alumni Association Executive Committee, especially the
subcommittee chairs and Marianne Ritchie, MD ’80, who are the bedrock of
our organization; and past President John Moore, MD, who showed me the
ropes before sadly passing away last fall. And I give special thanks to Vince
Armenti, PhD ’79, MD ’82, who will assume the presidency this April. He has
always been here for me and will represent us well over the next few years.

And, of course, I thank the thousands of alumni who make up this great organization. I leave you with
one last thought. JMC has given us all lifelong gifts: a stellar education, family, friends and an alma
mater that is always a source of great pride. Please join your fellow graduates and give back to JMC
every year. Don’t let any more time pass by before you do so; tomorrow will be here before you know it.

George Valko, MD ’86
President, JMC Alumni Association

a candidate in psychoanalytic
training at the Psychoanalytic
Center of Philadelphia.

’99

Benjamin L. Hoch, associate
professor of surgical pathology
at the University of Washington
Medical Center, has been promoted
to director of the school’s residency
training program. Residents in the
pathology department recently
presented him with an outstanding
teacher award. Hoch lives in
Snohomish, Wash.

’00

Michael A. Baumholtz welcomed
his second child, Audrey, in
April 2011. He works in Temple
University School of Medicine’s
division of plastic and reconstructive
surgery and lives in Wynnewood, Pa.

’07

Meghan Raleigh recently returned
from Tikrit, Iraq, where she served
as a U.S. Army battalion surgeon
for the 4th Infantry Division. She
reports that she was packing some
books from a physical therapy
clinic and found one on shoulder
injuries in sports written by
Phillip J. Marone, MD ’57, MS ’07,
associate dean of JMC alumni
relations and executive director
of the JMC Alumni Association.
“It was like a small piece of home
to be reminded of Jefferson.
All of the sports medicine and
physical diagnosis training I had
at Jefferson and beyond has
been high-yield in taking care
of soldiers,” Raleigh writes.

Post Graduate

James Medina, MD, PG, ’02,
practices emergency medicine in
Lancaster, Pa., and has released
an iPhone/iPad application called
Coaching Wizard to assist soccer
coaches with real-time game
management. The app tracks
individuals’ playing time, assists
with player substitutions, records
statistics and assists with email
communication.

Charitable Gift
ANNUITY PROGRAM

A charitable gift annuity can provide you with
payments for life while supporting the mission
of Jefferson.
The income from a charitable gift annuity is fixed
at the time of the gift and will not vary over your
lifetime. With the volatility of the economy
and interest rates, this type of gift ensures you
an annual income that will not change.

For more information,
please contact Jennifer Welsh
at the Jefferson Foundation
at 1-877-JEFF-GIFT (toll free)
or 215 -955 -9446 (local).

Jefferson Foundation recommends that you consult with your financial adviser on the best way to take advantage
of this giving opportunity.
THOMAS JEFFERSON UNIVERSITY AND HOSPITALS
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Alumnus Profile

Irving Danesh, MD:
The Physician
Behind the Scenes

Danesh with “Royal Pains”
star Mark Feuerstein

A 16-year-old heir to the inventor of the kitchen blender has just stolen
and crashed his father’s Ferrari. When he arrives home after the accident, he collapses on the marble floor of his parents’ mansion.
Hank Lawson, a concierge physician, happens to be on the scene. He rips
open the boy’s shirt to find the telltale bruises of hemophilia and quickly
diagnoses the boy with a pericardial tamponade. Lawson, who has no
supplies, sends the boy’s girlfriend to gather his Factor VIII blood-clotting
kit, a razor blade, a Bic pen, duct tape, a plastic bag and a bottle of vodka.
Using the vodka as a sterilizer, he slices into the boy’s chest with
the razor and drains blood out of the pericardial sac via the barrel
of the pen. Then he seals the wound with the bag and duct tape. The
boy survives. Just another day at the office for Hank Lawson – and
for Irving Danesh, MD, graduate of Thomas Jefferson University
Hospital’s first emergency medicine residency class in 1986.
Danesh, the medical consultant for the USA Network’s show
“Royal Pains,” devised the fictional scene above, which appeared in the
show’s first episode. Danesh is involved in all aspects of production,
including researching bizarre but true medical scenarios; working
with the show’s writers to develop medical scenes; assuring medical
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“I am so lucky. The people at my hospital are very kind. They’re
accuracy; and advising the prop department on such projects as
proud that I work on ‘Royal Pains’ and give me the freedom to work
building lifelike chests for Lawson to slice open with razor blades.
“We had to reshoot that scene after the pump for the gushing blood part time when the show is in production,” says Danesh, who is also
didn’t work,” Danesh explains about the pericardium scene, which writing a novel and is contracted to write a medical book with one of
also led to recognition from the National Hemophilia Foundation for the show’s actor’s wives about the so-called “MacGyvers” in the show.
Named after the 1980s television series that used a similar
promoting public awareness of the disease. “I remember working with
patients at Jefferson’s hemophilia center. I definitely drew upon my concept, the “MacGyvers” in the world of “Royal Pains” refer to
scenarios where Lawson improvises to create handy medical tools
experience there for that scene.”
The show’s creator, Andrew Lenchewski, first approached Danesh at a using household items (and often vodka) that save lives. Other than
wedding in Los Angeles and told him about his concept for a show about the timing (“Sometimes you need to cure a disease in 24 hours on
a concierge physician to the rich and famous in the Hamptons in New the show,” says Danesh), he tries to ensure that the scenarios are
York. And when Lenchewski said he wanted the medical scenarios to be medically plausible.
as real as possible and that he hoped to tap him for his expertise, Danesh
Danesh enjoys thinking up “MacGyvers” and finding rare but true
was excited but skeptical that the show would ever come to fruition.
medical cases for the show, such as when one character acquires lead
A few months later, Danesh, who lives in Boston, received a poisoning from buckshot or when a bad lightbulb causes reflex epilepsy.
called from Lenchewski. He had sold the show to USA and needed Danesh himself admits to a not-so-rare affliction. “I’m a former TV
Danesh’s help with the medical scenes. Danesh now splits his time addict,” he says. “So seeing how TV is made – about camera angles,
between consulting on the show in New York and practicing emer- how to shoot a scene, how to fake drawing blood into a syringe or that
gency medicine at Lawrence General Hospital in Massachusetts.
oatmeal makes great fake vomit – it’s been a blast.”

InMemoriam

’40

William A. Cappiello, 96, of
Jupiter, Fla., died Jan. 5, 2011.
Cappiello served in the U.S. Army
Medical Corps in World War
II and completed his surgical
training at Newark City Hospital
and Presbyterian Hospital in
Newark, N.J., and at NYU Bellevue
Hospital in New York. He ran a
private practice in Levittown, Pa.,
for more than 30 years and served
as chief of surgery at Rancocas
Valley Hospital in Willingboro,
N.J., and St. Mary Hospital in
Langhorne, Pa. He is survived
by four sons, William, MD ’76;
John; Robert; and Richard; and
six grandchildren. His wife of 45
years, Elizabeth, died in 1994.

’47

John A. Koltes, 88, of Philadelphia,
longtime clinical professor of
psychiatry and human behavior,
died Sept. 29, 2011. He is survived
by his wife, Nancy; four children;
seven grandchildren; and one sister.

’48

Joseph P. Kenna, 88, of York, Pa.,
died Sept. 24, 2010. Kenna served as
a U.S. Air Force officer during the
Korean War. During his 50-year career,
he practiced family and emergency
medicine as well as surgery. He most
recently worked at St. Joseph’s Hospital
in Lancaster, Pa. He is survived by
his wife of 62 years, Marie; one son,
Joseph; three daughters, Diane, Karen
and Denise, MD ’82; six grandchildren; and three great-grandchildren.

’53

Marvin C. Snyder, 82, of Lehighton,
Pa., died July 22, 2011. Snyder was
a family physician for 40 years
and served on the medical staff
of the Gnaden Huetten Memorial
Hospital in Lehighton for 35 years.
He is survived by his wife of 56
years, MaryAnn; five sons; and
two daughters.

’55

Joseph S. Harun, 86, of Lower
Gwynedd, Pa., died May 17, 2011.
Harun opened a dermatology practice in Philadelphia in 1957. He later
helped develop penicillamine to treat
severe arthritis and was involved
with the development of new uses
for clofazimine, a drug intended for
the treatment of tuberculosis that
researchers discovered also could be
used to treat leprosy and infections
in AIDS patients. He is survived by
his wife of 59 years, Germaine; two
daughters; and three sons.

Donald E. Stoudt died Aug. 14,
2010. Stoudt served in the U.S.
Navy from 1956 to 1958 before
serving a residency in neurology
at Georgetown University. He
then ran a private neurology
practice in Reading, Pa., until
his retirement in 1981. He is
survived by his wife, Mary Lu,
who completed Jefferson’s diploma
nursing program in 1954; four
children; and two grandchildren.

’56

James R. Regan, 80, of Bethlehem,
Pa., died July 20, 2011. Regan was a
physician internist in private practice until he retired. He served his
country honorably during peacetime
in the U.S. Air Force. He is survived
by three sons and one daughter.

’59

Kenneth P. Johnson, 79, of Lutherville,
Md., died Sept. 3, 2011. Johnson was
former chairman of neurology at
the University of Maryland School
of Medicine and an internationally
recognized expert on multiple sclerosis. His work led to FDA approval
of several new treatments for
multiple sclerosis. Johnson was the
founder of the Americas Committee
for Treatment and Research in
Multiple Sclerosis and was head of
the Maryland Center for Multiple
Sclerosis, which he also founded. He
enjoyed traveling and camping. He
is survived by his wife, Jacquelyn;

three sons; a daughter; a sister; and
two grandchildren.

’68

Theodore J. Skowronski, 68, of
Dresher, Pa., died Sept. 6, 2011.
Skowronski worked at Abington
Memorial Hospital for 41 years. He
served in the U.S. Army during
the Vietnam War at Virginia’s
Kenner Army Health Clinic at Fort
Lee. His love for aviation spawned
the opportunity to become a flight
surgeon, and he made many helicopter trips to Walter Reed Army
Hospital. He played the accordion
and had a passion for photography.
He is survived by his wife, Daria;
two sons, Paul and Greg; and five
grandchildren.

Rubin was an expert on liver pathology. His research
focused on a kind of cell signaling known as insulinlike growth factor 1 – an important hormone known
to keep cancer cells growing. His research has
been published in more than 100 professional journals. He was co-editor of the fifth and sixth editions
of Rubin’s Pathology, a medical textbook first
published by his father, Emanuel Rubin.
Rubin, who was named physician of the year in 2000
by the American Liver Foundation, headed Jefferson’s

Average number of people
hospitalized annually in the
United States for flu-related
complications: > 200,000

Post Graduate

Ping Nan Cheng, MD, PG, ’79, 70,
died Aug. 24, 2011. Descended from
Cheng Ch’eng-kung, the merchant
pirate who established ethnic Chinese
rule over the island of Taiwan in the
17th century, he trained in England
prior to coming to the United States
to further his neurosurgical acumen.
He served a neurological surgery residency at Jefferson. He enjoyed fishing,
philosophy, attempting (not always
successfully) to fix things around
the house and discussing interesting
neurosurgical cases. He is survived by
his wife, an obstetrician-gynecologist,
and two children: a neurologist and
an emergency medicine physician.

Raphael Rubin, MD,
Professor of Pathology and Cell Biology
Raphael Rubin, MD, 55, of Merion, Pa., professor of
pathology and cell biology and a faculty member at
Jefferson since 1986, died of brain cancer Sept. 18.

By Numbers

liver study unit and worked closely with liver transplant
teams. Last April, his portrait was unveiled at JMC.
A talented musician who played piano and
excelled at the violin, Rubin performed as a
soloist with the Main Line Symphony and with
the Merion Trio. He played in benefit concerts
for Jefferson and for Kohelet Yeshiva High
School in Merion, which his daughters attended.
He and his wife, Rene Rothstein-Rubin, established a science education fund for the school.

Influenza
Body Mass Index that
• puts
people at highest risk
for developing flu-related
complications: ≥ 40
Range of yearly flu-associated deaths
between 1976 and 2006 in the
United States: 3,000 to 49,000

Average number of children younger
than 5 who are hospitalized due to
flu-related complications every year
in the United States: 20,000

Percent

Paul E. Chodoff, 97, of Bethesda,
Md., died Aug. 21, 2011. Chodoff
opened his Washington, D.C., practice in the late 1940s and continued
to see patients until he was 92. He
served in World War II and treated
returning servicemen and women
for what would later be called posttraumatic stress disorder. He is
survived by four children.

In Thousands

’38
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Winter is upon us – and so is flu season. Flu season’s
severity varies depending on factors including the
strain and virulence of flu virus, how well the season’s
flu vaccine matches the virus and the percentage of
the population that has been vaccinated. While the
flu may be unpredictable from season to season or
person to person, here are some things we do know
about the virus.
Percentage of people between ages 50 and 64 who have
one or more health conditions that put them at higher risk
for flu-related complications: 30%
On average, percentage of U.S. population that gets the flu
each year: 5% and 20%

• Peak month for influenza: February
• Ideal month to get the flu vaccine: September
age for receiving flu vaccine:
• Recommended
over 6 months
Ages at which people are at greatest risk for flu-related
• complications:
< 5 and ≥ 65

In addition to his wife, Rubin is survived by sons
Jascha, Saul and Judah; daughters Zipporah, Sophie,
Zahava and Batsheva; two brothers; and a sister.
Figures from the Centers for Disease Control and Prevention.
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Announcing Jefferson’s private

“Social Network”
for Jefferson Medical College Alumni ONLY

Stay in touch with your
medical college friends
and colleagues online –
just a few keyboard
clicks away.

connect.jefferson.edu

